UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date
UnitedHealth shares slipped about 0.8% to $344 in after-hours trading Friday after House committees summoned CEO Stephen Hemsley and other executives to testify on affordability Jan. 22. Senate Democrats set a Jan. 28 deadline for UnitedHealth to respond to a nursing-home probe tied to its Optum unit.